Illustration of amyloid plaques amongst neurons. Amyloid plaques are characteristic features of Alzheimer's disease. They lead to degeneration of the affected neurons, which are destroyed through the activity of microglia cells.

Amyloid-Tau- Neurodegeneration (ATN) Profile

Labcorp is the first company to make a fully blood-based ATN Profile commercially available - giving physicians a simple, objective test for Alzheimer's disease pathology that can help shorten the time to diagnosis.

Quick Links & Resources

For Neurologists

Learn More

For Primary Care Providers

Learn More

For Patients

Learn More

Advancing Alzheimer's Testing

We are working with blood-based biomarkers, like pTau and Nfl, and collaborating with pharmaceutical and diagnostic partners to develop tests that identify, diagnose and monitor patients with AD.
 

Labcorp can help meet your neurology needs

Contact a Labcorp representative to learn more about how we can help meet your neurology testing needs
 

Contact a Representative

Neurology 

Labcorp is accelerating technologies from the lab to the clinic. As a single lab services provider, we are expanding our comprehensive neurology portfolio to help you do more for your patients. Please click the link below to learn more about our full neurology program.

Learn More